Customs Benefits for Pharmaceutical Companies Extended Until 2028
The President of Uzbekistan made this announcement
Pharmaceutics
Mirziyoyev Unveils UZS 20 Billion Initiative to Strengthen Pharma Sector
The funds will be provided as grants
Juris Bundulis, Chairman of the Board of Olainfarm: Compelling Investment Opportunity in Promising Market
The Latvian pharmaceutical company aims to 'revitalise' Central Asia and has specific plans for Uzbekistan.
State investments and regulatory framework
IQVIA outlines growth conditions for Uzbekistan’s pharmaceutical market
Vladislav Bessarabov: Standardisation of Rules as a Growth Factor for the Pharmaceutical Business
What challenges do foreign companies face in the Central Asian market